Charles River Laboratories International (CRL) Revenue — Quarter Ended Mar 28, 2026
Revenue for the quarter increased compared to the same period last year. The reported revenue also showed a slight sequential improvement from the immediately preceding quarter.
Key takeaway
Quarter ended Mar 28, 2026 · FY2026 Q1
Revenue for the quarter increased compared to the same period last year. The reported revenue also showed a slight sequential improvement from the immediately preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$995.8M
Revenue reported for this quarter.
Quarter-over-quarter
+0.2%
Change from the immediately preceding quarter.
Year-over-year
+1.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 28, 2025 | $1B | +0.6% |
| Sep 27, 2025 | $1B | -0.5% |
| Dec 27, 2025 | $994.2M | -0.8% |
| Mar 28, 2026 | $995.8M | +1.2% |
Revenue performance
The company reported higher revenue than in the prior-year quarter, continuing a trend of year-over-year growth. On a sequential basis, revenue edged up from the previous quarter.
Quarterly comparison
Compared with the immediately preceding quarter, revenue increased modestly. Relative to the same quarter one year earlier, revenue was also higher.
What to watch
The filing includes forward-looking statements about non-human primate supply chain diversification and ongoing litigation, which may affect future results.